“…Several findings have been revealed, such as: (1) differences between electrical conductivities (η k , k = 1,2) and electrical permittivities (ε k , k = 1,2) of the untreated malignant tumour (k = 1) and the surrounding healthy tissue (k = 2) [11]; (2) these two physical properties as a potential diagnostic method [16]; (3) differences between ionic current (due to the movement of charged ions) and faradic current (produced by electrons exchange from reduction and/or oxidation of biochemical molecules) in cancer and surrounding healthy tissue [8]; (4) the existence of chemical and electrical (charged negatively) environments in cancer cells and untreated tumours [1,4,14] and their key roles in the genesis, growth, progression, metastasis and treatment of cancer [17]; (5) the impact of tumour microenvironment on its electrical properties [16]; (6) the breakdown of intercellular communication (gap junction) in the tumour due to low regulation in expression of the connexin [12,18]; (7) negative electrical biopotentials in the tumour and positive electrical biopotentials in the surrounding healthy tissue [12][13][14]; (8) cancer cells and some cells of the immune system negatively charged [14]; (9) weaker electrical coupling among cancer cells and the association of deregulation of intercellular communication with tumourigenicity and metastasis of the cancer [14,18]; (10) bioelectronic cancer regulator as an initiator of the mitosis and deoxyribonucleic acid synthesis; and (11) correction of alterations in the electrical communication system of cancer by manipulating its bioelectrical properties, known as bioelectronic medicine [8].…”